Literature DB >> 22178300

Substantia nigra vulnerability after a single moderate diffuse brain injury in the rat.

Daniel R van Bregt1, Theresa Currier Thomas, Jason M Hinzman, Tuoxin Cao, Mei Liu, Guoying Bing, Greg A Gerhardt, James R Pauly, Jonathan Lifshitz.   

Abstract

Dementia and parkinsonism are late-onset symptoms associated with repetitive head injury, as documented in multiple contact-sport athletes. Clinical symptomatology is the likely phenotype of chronic degeneration and circuit disruption in the substantia nigra (SN). To investigate the initiating neuropathology, we hypothesize that a single diffuse brain injury is sufficient to initiate SN neuropathology including neuronal loss, vascular disruption and microglial activation, contributing to neurodegeneration and altered dopamine regulation. Adult, male Sprague-Dawley rats were subjected to sham or moderate midline fluid percussion brain injury. Stereological estimates indicated a significant 44% loss of the estimated total neuron number in the SN at 28-days post-injury, without atrophy of neuronal nuclear volumes, including 25% loss of tyrosine hydroxylase positive neurons by 28-days post-injury. Multi-focal vascular compromise occurred 1-2 days post-injury, with ensuing microglial activation (significant 40% increase at 4-days). Neurodegeneration (silver-stain technique) encompassed on average 21% of the SN by 7-days post-injury and increased to 29% by 28-days compared to sham (1%). Whole tissue SN, but not striatum, dopamine metabolism was altered at 28-days post-injury, without appreciable gene or protein changes in dopamine synthesis or regulation elements. Together, single moderate diffuse brain injury resulted in SN neurovascular pathology potentially associated with neuroinflammation or dopamine dysregulation. Compensatory mechanisms may preserve dopamine signaling acutely, but subsequent SN damage with aging or additional injury may expose clinical symptomatology of motor ataxias and dementia. Copyright Â
© 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22178300      PMCID: PMC3294202          DOI: 10.1016/j.expneurol.2011.12.003

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  100 in total

1.  Neuroinflammatory responses after experimental diffuse traumatic brain injury.

Authors:  Brian Joseph Kelley; Jonathan Lifshitz; John Theodore Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

Review 2.  Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease.

Authors:  David Sulzer
Journal:  Trends Neurosci       Date:  2007-04-05       Impact factor: 13.837

3.  Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat.

Authors:  S Breit; R Bouali-Benazzouz; R C Popa; T Gasser; A L Benabid; A Benazzouz
Journal:  Exp Neurol       Date:  2006-12-29       Impact factor: 5.330

4.  Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injury.

Authors:  Hong Qu Yan; Xiecheng Ma; Xiangbai Chen; Youming Li; Lifang Shao; C Edward Dixon
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

5.  Changes in blood-brain barrier permeability to large and small molecules following traumatic brain injury in mice.

Authors:  M D Habgood; N Bye; K M Dziegielewska; C J Ek; M A Lane; A Potter; C Morganti-Kossmann; N R Saunders
Journal:  Eur J Neurosci       Date:  2007-01       Impact factor: 3.386

6.  Perisomatic thalamic axotomy after diffuse traumatic brain injury is associated with atrophy rather than cell death.

Authors:  Jonathan Lifshitz; Brian Joseph Kelley; John Theodore Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2007-03       Impact factor: 3.685

Review 7.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.

Authors:  Heiko Braak; Jürgen R Bohl; Christian M Müller; Udo Rüb; Rob A I de Vos; Kelly Del Tredici
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

8.  Evolution of post-traumatic neurodegeneration after controlled cortical impact traumatic brain injury in mice and rats as assessed by the de Olmos silver and fluorojade staining methods.

Authors:  Edward D Hall; Ying Deng Bryant; Wongil Cho; Patrick G Sullivan
Journal:  J Neurotrauma       Date:  2008-03       Impact factor: 5.269

Review 9.  The etiopathogenesis of Parkinson disease and suggestions for future research. Part I.

Authors:  Irene Litvan; Glenda Halliday; Mark Hallett; Christopher G Goetz; Walter Rocca; Charles Duyckaerts; Yoav Ben-Shlomo; Dennis W Dickson; Anthony E Lang; Marie-Francoise Chesselet; William J Langston; Donato A Di Monte; Thomas Gasser; Theo Hagg; John Hardy; Peter Jenner; Eldad Melamed; Richard H Myers; Davis Parker; Donald L Price
Journal:  J Neuropathol Exp Neurol       Date:  2007-04       Impact factor: 3.685

10.  The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerability.

Authors:  D C Duke; L B Moran; R K B Pearce; M B Graeber
Journal:  Neurogenetics       Date:  2007-01-09       Impact factor: 2.660

View more
  22 in total

Review 1.  Neurotransmitter changes after traumatic brain injury: an update for new treatment strategies.

Authors:  Jennifer L McGuire; Laura B Ngwenya; Robert E McCullumsmith
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

2.  Does time heal all wounds? Experimental diffuse traumatic brain injury results in persisting histopathology in the thalamus.

Authors:  Theresa Currier Thomas; Sarah B Ogle; Benjamin M Rumney; Hazel G May; P David Adelson; Jonathan Lifshitz
Journal:  Behav Brain Res       Date:  2016-12-29       Impact factor: 3.332

3.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

4.  Traumatic brain injuries during development disrupt dopaminergic signaling.

Authors:  Kate Karelina; Kristopher R Gaier; Zachary M Weil
Journal:  Exp Neurol       Date:  2017-08-09       Impact factor: 5.330

Review 5.  Sex differences in mitochondrial (dys)function: Implications for neuroprotection.

Authors:  Tyler G Demarest; Margaret M McCarthy
Journal:  J Bioenerg Biomembr       Date:  2014-10-08       Impact factor: 2.945

6.  Objective Morphological Quantification of Microscopic Images Using a Fast Fourier Transform (FFT) Analysis.

Authors:  Samuel E Taylor; Tuoxin Cao; Pooja M Talauliker; Jonathan Lifshitz
Journal:  Curr Protoc Essent Lab Tech       Date:  2013-10-23

7.  Morphological and genetic activation of microglia after diffuse traumatic brain injury in the rat.

Authors:  T Cao; T C Thomas; J M Ziebell; J R Pauly; J Lifshitz
Journal:  Neuroscience       Date:  2012-09-06       Impact factor: 3.590

8.  Lithium Improves Dopamine Neurotransmission and Increases Dopaminergic Protein Abundance in the Striatum after Traumatic Brain Injury.

Authors:  Shaun W Carlson; C Edward Dixon
Journal:  J Neurotrauma       Date:  2018-08-13       Impact factor: 5.269

9.  Olfactory Bulb Excitotoxicity as a Gap-Filling Mechanism Underlying the Link Between Traumatic Brain Injury-Induced Secondary Neuronal Degeneration and Parkinson's Disease-Like Pathology.

Authors:  Concepció Marin; Mireya Fuentes; Isam Alobid; Valeria Tubita; María Jesús Rojas-Lechuga; Joaquim Mullol
Journal:  Neurochem Res       Date:  2022-01-24       Impact factor: 3.996

Review 10.  Role of the Dopaminergic System in the Striatum and Its Association With Functional Recovery or Rehabilitation After Brain Injury.

Authors:  Antonio Verduzco-Mendoza; Paul Carrillo-Mora; Alberto Avila-Luna; Arturo Gálvez-Rosas; Adriana Olmos-Hernández; Daniel Mota-Rojas; Antonio Bueno-Nava
Journal:  Front Neurosci       Date:  2021-06-24       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.